In a ceremony in Stockholm on Monday, the Nobel Committee announced that the 2026 Nobel Prize in Physiology or Medicine will be shared equally by three researchers whose work has opened a new era in neuroscience. Karl Deisseroth of the United States, and German scientists Peter Hegemann (71) and Georg Nagel (73) were recognized for creating and refining optogenetics – a method that turns specific brain cells into light‑sensitive switches.
From algae to the brain
Hegemann and Nagel first discovered a light‑sensitive protein called channelrhodopsin in single‑celled algae known as Chlamydomonas. This protein responds to light and generates electrical impulses, a property that made it an ideal tool for controlling nerve cells. Building on that discovery, Deisseroth introduced the gene that encodes channelrhodopsin into the neurons of laboratory animals. By shining laser light on those modified cells, he was able to activate or silence them with remarkable precision.
Early experiments around 2007 demonstrated that light could drive the movement of mouse whiskers, proving the concept that neural activity could be governed by a simple light switch. Since then, optogenetics has become a cornerstone technique for mapping the neural circuits that underlie specific memories, emotions, and behaviors.
Impact on research and medicine
The Nobel Committee highlighted how optogenetics has transformed the study of neurological and psychiatric disorders. Researchers can now pinpoint the exact groups of neurons that control pain perception, social interaction, thirst, food intake, reward pathways and attention. This level of detail offers unprecedented insight into conditions such as depression, anxiety, schizophrenia, Alzheimer’s disease and Parkinson’s disease.
Beyond basic science, the technology is already being explored for therapeutic applications. In one promising line of work, scientists have inserted a channelrhodopsin‑like protein into the retinas of individuals blinded by retinitis pigmentosa. Using special glasses that emit patterned light, some patients have regained the ability to detect objects on a table. Other teams are investigating how optogenetics might improve cochlear implants for hearing loss.
Recognition and prize details
David Pendlebury, head of research analysis at Clarivate’s Institute for Scientific Information, called the award a “profound impact of a field that has fundamentally changed how scientists understand the brain and nervous system.” The three laureates will each receive 4 million Swedish krona, totaling 12 million krona (approximately $1.2 million USD).
All three scientists expressed surprise at the honor. Committee secretary‑general Thomas Perlmann noted that Deisseroth was “very tired” when he learned of the prize, but he quickly woke up to share the news with his fellow laureates.
Future directions
Optogenetics continues to evolve, with researchers seeking to refine the technique for human use, develop safer viral delivery methods, and combine light‑based control with advanced imaging. The Nobel recognition underscores the promise of this approach to not only deepen our understanding of the brain but also to pave the way for novel treatments that could alleviate suffering for millions.
Original reporting: El Paso News (HLL/CB) — read the source article.
